Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Monga

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annual Review of Pharmacology and Toxicology|August 27, 2002
Signal transduction--directed cancer treatmentsEdward A Sausville, Yusri Elsayed, Manish Monga, et al.
Clinical & Experimental Metastasis|December 6, 2013
Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignanciesSoumit K Basu, Scot C Remick, Manish Monga, et al.
Expert Review of Endocrinology & Metabolism|February 10, 2019
Sorafenib and thyroid cancerChandler Park, Jessica Perini, Roger W Farmer, et al.
Plos One|September 10, 2016
Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung CancerAlexander Chi, Sijin Wen, Manish Monga, et al.
Frontiers in Oncology|July 8, 2014
Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyondAlexander Chi, Nam Phong Nguyen, James S Welsh, et al.
Clinical Chemistry|November 21, 2015
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with CrizotinibTodd Hembrough, Wei-Li Liao, Christopher P Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaQin C Ryan, Donna Headlee, Milin Acharya, et al.
Cancer|May 11, 2016
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, et al.
The West Virginia Medical Journal|December 17, 2009
Building a statewide clinical trials network for cancer care in West VirginiaJame Abraham, James Keresztury, John Azar, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annual Review of Pharmacology and Toxicology|August 27, 2002
Signal transduction--directed cancer treatmentsEdward A Sausville, Yusri Elsayed, Manish Monga, et al.
Clinical & Experimental Metastasis|December 6, 2013
Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignanciesSoumit K Basu, Scot C Remick, Manish Monga, et al.
Expert Review of Endocrinology & Metabolism|February 10, 2019
Sorafenib and thyroid cancerChandler Park, Jessica Perini, Roger W Farmer, et al.
Plos One|September 10, 2016
Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung CancerAlexander Chi, Sijin Wen, Manish Monga, et al.
Frontiers in Oncology|July 8, 2014
Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyondAlexander Chi, Nam Phong Nguyen, James S Welsh, et al.
Clinical Chemistry|November 21, 2015
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with CrizotinibTodd Hembrough, Wei-Li Liao, Christopher P Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphomaQin C Ryan, Donna Headlee, Milin Acharya, et al.
Cancer|May 11, 2016
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, et al.
The West Virginia Medical Journal|December 17, 2009
Building a statewide clinical trials network for cancer care in West VirginiaJame Abraham, James Keresztury, John Azar, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Pageof 2